Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey.
Trueba G, Jeyaseelan V, Lopez L, Mainou BA, Zhang Y, Whittembury A, Valarezo AJO, Baquero G, de Aguinaga RR, Salinas LJZ, Mancheno MGS, Chacho DEM, Quentin E, Chevez AE, Rey-Benito G, Mach O.
Trueba G, et al. Among authors: mancheno mgs.
Lancet Reg Health Am. 2022 Jul;11:None. doi: 10.1016/j.lana.2022.100235.
Lancet Reg Health Am. 2022.
PMID: 35865654
Free PMC article.